Exec-Edge – Page 67 – ExecEdge

Hear from Kevin Duffy, CEO of iFIT Live at ICR Conference 2024

Hear from Kevin Duffy, CEO of iFIT Live at ICR Conference 2024

  Exec Edge hosted a fireside chat at the 2024 ICR Conference with Kevin Duffy, CEO of iFIT. The in-person interview was joined by Editor-at-Large Jarrett Banks and they discussed the company’s latest brand campaigns and how they contribute to expand...

Tock Launches Multi-Experience Tables to Enhance Restaurant Offerings

Tock Launches Multi-Experience Tables to Enhance Restaurant Offerings

By Karen E. Roman Tock, a Squarespace, Inc. company (NYSE: SQSP), said its new service can help restaurants drive profitability while offering unique experiences to diners. Multi-Experience Tables allow restaurants to offer customers distinctive experiences at the same table, the company...

DecisionRx Secures $100 Million Credit Facility from Carlyle

DecisionRx Secures $100 Million Credit Facility from Carlyle

  By Karen E. Roman DecisionRx, Inc., a value-based healthcare company focused on minimizing healthcare costs by addressing medication failure, announced a $100 million credit facility from global investment firm Carlyle. Carlyle also obtained an option to acquire 25% of...

DecisionRx Secures $100 Million Credit Facility from Carlyle

DecisionRx Secures $100 Million Credit Facility from Carlyle

  By Healthcare Edge Editorial Staff DecisionRx, Inc., a value-based healthcare company focused on minimizing healthcare costs by addressing medication failure, announced a $100 million credit facility from global investment firm Carlyle. Carlyle also obtained an option to acquire 25%...

Eterna Therapeutics Appoints Sanjeev Luther as President and CEO

Eterna Therapeutics Appoints Sanjeev Luther as President and CEO

By Healthcare Edge Editorial Staff Eterna Therapeutics Inc. (Nasdaq: ERNA) said it appointed Sanjeev Luther as incoming President and Chief Executive Officer from Jan. 1, 2024. Mr. Luther emphasized his commitment to advancing the reach and promise of mRNA cell...

ProSomnus Treatment for Sleep Apnea Effective, Study Shows

ProSomnus Treatment for Sleep Apnea Effective, Study Shows

By Healthcare Edge Editorial Staff ProSomnus, Inc. (NASDAQ: OSA), a pioneer in non-CPAP Obstructive Sleep Apnea (OSA) therapy, has revealed that its precision oral appliance therapy (OAT) devices effectively treat OSA, according to a study published by the Cureus Journal...

Input your search keywords and press Enter.